Literature DB >> 18772732

[Thyroid cancer in patients with Grave's Disease].

R Mssrouri1, S Benamr, A Essadel, J Mdaghri, El H Mohammadine, M-K Lahlou, A Taghy, A Belmahi, B Chad.   

Abstract

OBJECTIVE: To evaluate the incidence of thyroid carcinoma in patients operated on for Graves' disease, to identify criteria which may predict malignancy, and to develop a practical approach to determine the extensiveness of thyroidectomy. PATIENTS AND METHODS: Retrospective study of all patients who underwent thyroidectomy for Graves' disease between 1995 and 2005.
RESULTS: 547 patients underwent subtotal thyroidectomy for Graves' disease during this period. Post-operative pathology examination revealed six cases of thyroid cancer (1.1%). All six cases had differentiated thyroid carcinoma (papillary carcinoma in 3 cases, follicular carcinoma in 2 cases and papillo-follicular carcinoma in 1 case). The indication for initial thyroidectomy was a palpable thyroid nodule in 3 cases (50%), failure of medical treatment for Grave's disease in 2 cases (33%), and signs of goiter compression in 1 case (17%). Five patients underwent re-operative total thyroidectomy.
CONCLUSION: This study shows that while malignancy in Grave's disease is uncommon, the presence of thyroid nodule(s) in patients with Grave's disease may be considered as an indication for radical surgery. The most adequate radical surgery in this situation is to perform a total thyroidectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18772732

Source DB:  PubMed          Journal:  J Chir (Paris)        ISSN: 0021-7697


  2 in total

1.  Papillary thyroid carcinoma and inflammation.

Authors:  Laura Fugazzola; Carla Colombo; Michela Perrino; Marina Muzza
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

2.  Hyperfunctioning papillary thyroid carcinoma: A case report with literature review.

Authors:  Abdulwahid M Salih; F H Kakamad; Han Nihad
Journal:  Int J Surg Case Rep       Date:  2016-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.